AstraZeneca Pharma India (BOM:506820) Total Stockholders Equity : ₹7,119 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is AstraZeneca Pharma India Total Stockholders Equity?

AstraZeneca Pharma India's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹7,119 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. AstraZeneca Pharma India's Book Value per Share for the quarter that ended in Mar. 2024 was ₹284.77. The ratio of a company's debt over equity can be used to measure how leveraged this company is. AstraZeneca Pharma India's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.01.

AstraZeneca Pharma India Total Stockholders Equity Historical Data

The historical data trend for AstraZeneca Pharma India's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Pharma India Total Stockholders Equity Chart

AstraZeneca Pharma India Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Stockholders Equity

Get a 7-Day Free Trial

3,644.40

4,561.70

5,113.90

5,886.90

7,119.17

AstraZeneca Pharma India Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															5,886.90	-	6,549.65	-	7,119.17

AstraZeneca Pharma India (BOM:506820) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

AstraZeneca Pharma India's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(7119.174	-	0)	/	25
	=	284.77

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

AstraZeneca Pharma India's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(18.146	+	27.836)	/	7119.174
	=	0.01

AstraZeneca Pharma India Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of AstraZeneca Pharma India's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca Pharma India (BOM:506820) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca Pharma India Ltd (BOM:506820) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

ASTRAZEN:India

Address

Outer Ring Road, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Bangalore, KA, IND, 560 045

Website

https://www.astrazeneca.com

AstraZeneca Pharma India Ltd is engaged in the manufacture, distribution, and marketing of pharmaceutical products. Its only operating segment being Healthcare. The company generates revenue from the sale of products such as Tablets, Injectables, and Inhalation. Geographically, it derives a majority of revenue from India. It focuses on areas such as Cardiovascular, Renal and Metabolism (CVRM), Oncology, Respiratory, Inflammation and Autoimmunity, Neuroscience and Infection and Vaccines.

AstraZeneca Pharma India (BOM:506820) Headlines

No Headlines